Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients
Clinical trial NCT05147051 · COMPLETED
Trial details
- NCT number
- NCT05147051
- Sponsor
- POLYSAN Scientific & Technological Pharmaceutical Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2022-05-23
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.